Aarti Surfactants Limited reported a 30% year-on-year increase in operational revenue to ₹859.13 crore for FY26, driven by strong volume growth and market expansion.

Despite the top-line surge, profitability metrics contracted. EBITDA declined 5% to ₹47.32 crore, causing the operating margin to shrink from 7.56% in FY25 to 5.51% in FY26. The company attributed this margin pressure to input cost volatility, freight fluctuations, and competitive pricing, as detailed in its investor presentation released alongside the 8th Annual General Meeting held on September 29, 2026.

Financial performance highlights

The standalone income statement reveals a divergence between revenue growth and bottom-line performance. While operational revenue rose significantly, total expenses increased at a similar pace, eroding margins. Net profit after tax fell 15% to ₹12.68 crore, with the PAT margin declining from 2.27% to 1.48%.

The board declared a final dividend of ₹1 per equity share, representing a 10% payout on the face value of ₹10. This decision was adopted by shareholders during the meeting, which saw the attendance of 58 members via Video Conferencing.

Business overview and strategic focus

Aarti Surfactants, established through the demerger of Aarti Industries' Home and Personal Care division in 2018, specialises in high-performance ionic, non-ionic, and speciality surfactants. The company serves over 100 customers across more than 50 countries, with a strategic focus on expanding its presence in the high-margin skincare segment.

Key operational metrics disclosed in the presentation include:

• Geographical Split: Domestic sales accounted for 82% of revenue, while international markets contributed 18%.
• Infrastructure: Operations are supported by two manufacturing units in Madhya Pradesh and Silvassa, along with a dedicated R&D centre in Navi Mumbai.
• Workforce: The company employs over 350 people and offers a portfolio of 50+ products.

CEO and Managing Director Nikhil Desai highlighted that the company navigated challenges by focusing on operational efficiencies and capacity utilisation. The presentation noted a 14% CAGR in sales achieved over the six years up to FY24, underscoring long-term growth momentum despite recent margin pressures.

Governance and resolutions

Shareholders approved several ordinary and special business items during the meeting. Key resolutions included:

• Adoption of standalone and consolidated financial statements for FY26.
• Declaration of a dividend of ₹1 per equity share.
• Re-appointment of Dattatray S. Galpalli as director retiring by rotation.
• Re-appointment of Nikhil P. Desai as CEO and Managing Director.
• Re-appointment of Santosh M. Kakade as Whole-time Director.
• Appointment of Vandana B. Patravale as Independent Director.
• Enhancement of borrowing limits and creation of charges on properties.

Chairman Mulesh Savla noted that the Statutory Auditors' Report and the Secretarial Audit Report for FY26 contained no qualifications, reservations, or adverse remarks. The voting process was overseen by Parikh & Associates, who were appointed as Scrutinizers.

What the numbers show

The FY26 results present a classic case of revenue-led growth masking margin erosion. While revenue expanded by 30%, EBITDA contracted by 5%, indicating that incremental sales came at a lower contribution margin or were offset by rising variable costs. The decline in ROCE from 11.54% to 9.72% and ROE from 6.61% to 5.27% further signals reduced capital efficiency.

However, the credit rating agency Crisil upgraded the company's long-term bank facilities rating to 'Crisil A-/Stable' from 'CARE BBB+/Stable' in September 2026. This upgrade suggests that despite the short-term margin dip, lenders view the company's liquidity profile and business risk as stable, likely supported by the robust top-line growth and diversified customer base.

Aarti Surfactants received a customs order imposing a penalty of ₹1.54 crore and directing the confiscation of goods valued at ₹2.30 crore. The action stems from incorrect classification of imported goods.

The order, issued by the Commissioner of Customs (NS-I) at Jawaharlal Nehru Custom House (JNCH), Nhava Sheva, also demands differential duty and interest. It targets both the company and its CEO & Managing Director, Nikhil Desai.

Regulatory Action Details

The Adjudicating Authority rejected the company's declared description of imported goods as "Dimethyl Lauryl Amine (DMLA)" under CTH 29212990. Instead, the goods were re-classified as a Cationic Surface Active Agent under CTH 34021200 of the Customs Tariff Act, 1975. This reclassification triggered the demand for differential duty and penalties.

Key components of the order include:

• Confiscation of seized goods weighing 171.444 MTs valued at ₹2.30 crore, with an option for redemption upon payment of a fine of ₹25 lakh.
• Confirmation of differential duty demand of ₹11.10 lakh on the confiscated goods.
• Holding additional goods weighing 2,275.963 MTs valued at ₹34.88 crore liable for confiscation due to non-availability.
• Confirmation of differential duty demand of ₹1.43 crore on the unavailable goods.
• Appropriation of ₹2.25 crore already paid by the company towards duty and interest.
• Imposition of a penalty of ₹1.54 crore on the company under Section 114A of the Customs Act, 1962.
• Direction to encash a Bond of ₹2.76 crore and Bank Guarantees of ₹35 lakh issued by Axis Bank Limited.

Penalties on Management

The regulatory action extends beyond the corporate entity to its leadership. Mr. Nikhil Desai, Director of the company, faces two separate penalties:

• A penalty of ₹10 lakh under Section 112(a) of the Customs Act, 1962.
• A further penalty of ₹10 lakh under Section 114AA of the Customs Act, 1962.

These personal liabilities highlight the direct oversight responsibilities attributed to the management regarding import compliance procedures.

Financial Impact and Response

The company stated that the aggregate financial impact, comprising differential duty, redemption fine, and penalty, is not expected to have any material impact on its operations at this stage. The liability has been partially met through previously paid amounts and secured instruments.

Aarti Surfactants is evaluating the order and intends to avail appropriate legal recourse by filing an appeal before the Customs, Excise and Service Tax Appellate Tribunal (CESTAT). The company will update stock exchanges on material developments in this matter.